These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 15625120)

  • 21. Analysis of KIT mutations in sporadic and familial gastrointestinal stromal tumors: therapeutic implications through protein modeling.
    Tarn C; Merkel E; Canutescu AA; Shen W; Skorobogatko Y; Heslin MJ; Eisenberg B; Birbe R; Patchefsky A; Dunbrack R; Arnoletti JP; von Mehren M; Godwin AK
    Clin Cancer Res; 2005 May; 11(10):3668-77. PubMed ID: 15897563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in the understanding of mastocytosis: the role of KIT mutations.
    Orfao A; Garcia-Montero AC; Sanchez L; Escribano L;
    Br J Haematol; 2007 Jul; 138(1):12-30. PubMed ID: 17555444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KIT (c-kit oncogene product) pathway is constitutively activated in human testicular germ cell tumors.
    Nakai Y; Nonomura N; Oka D; Shiba M; Arai Y; Nakayama M; Inoue H; Nishimura K; Aozasa K; Mizutani Y; Miki T; Okuyama A
    Biochem Biophys Res Commun; 2005 Nov; 337(1):289-96. PubMed ID: 16188233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of hematopoietic stem cells by the steel factor/KIT signaling pathway.
    Kent D; Copley M; Benz C; Dykstra B; Bowie M; Eaves C
    Clin Cancer Res; 2008 Apr; 14(7):1926-30. PubMed ID: 18381929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages.
    Kimura Y; Jones N; Klüppel M; Hirashima M; Tachibana K; Cohn JB; Wrana JL; Pawson T; Bernstein A
    Proc Natl Acad Sci U S A; 2004 Apr; 101(16):6015-20. PubMed ID: 15067126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathology of gastrointestinal stromal tumors.
    Hirota S; Isozaki K
    Pathol Int; 2006 Jan; 56(1):1-9. PubMed ID: 16398673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection of overexpressed and phosphorylated wild-type kit receptor in surgical specimens of small cell lung cancer.
    Tamborini E; Bonadiman L; Negri T; Greco A; Staurengo S; Bidoli P; Pastorino U; Pierotti MA; Pilotti S
    Clin Cancer Res; 2004 Dec; 10(24):8214-9. PubMed ID: 15623596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel germline mutation of KIT associated with familial gastrointestinal stromal tumors and mastocytosis.
    Hartmann K; Wardelmann E; Ma Y; Merkelbach-Bruse S; Preussner LM; Woolery C; Baldus SE; Heinicke T; Thiele J; Buettner R; Longley BJ
    Gastroenterology; 2005 Sep; 129(3):1042-6. PubMed ID: 16143141
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of constitutive activation of c-kit receptor tyrosine kinase.
    Tsujimura T; Kanakura Y; Kitamura Y
    Leukemia; 1997 Apr; 11 Suppl 3():396-8. PubMed ID: 9209403
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Kit--a hematopoietic cell essential receptor tyrosine kinase.
    Edling CE; Hallberg B
    Int J Biochem Cell Biol; 2007; 39(11):1995-8. PubMed ID: 17350321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
    Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interaction and functional cooperation between the serine/threonine kinase bone morphogenetic protein type II receptor with the tyrosine kinase stem cell factor receptor.
    Hassel S; Yakymovych M; Hellman U; Rönnstrand L; Knaus P; Souchelnytskyi S
    J Cell Physiol; 2006 Feb; 206(2):457-67. PubMed ID: 16155937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutations in the catalytic subunit of class IA PI3K confer leukemogenic potential to hematopoietic cells.
    Horn S; Bergholz U; Jücker M; McCubrey JA; Trümper L; Stocking C; Bäsecke J
    Oncogene; 2008 Jul; 27(29):4096-106. PubMed ID: 18317450
    [TBL] [Abstract][Full Text] [Related]  

  • 34. KIT activation in uterine cervix adenosquamous carcinomas by KIT/SCF autocrine/paracrine stimulation loops.
    Martinho O; Gonçalves A; Moreira MA; Ribeiro LF; Queiroz GS; Schmitt FC; Reis RM; Longatto-Filho A
    Gynecol Oncol; 2008 Nov; 111(2):350-5. PubMed ID: 18708242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential activity of c-KIT splice forms is controlled by extracellular peptide insert length.
    Phung B; Steingrímsson E; Rönnstrand L
    Cell Signal; 2013 Nov; 25(11):2231-8. PubMed ID: 23880320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gain-of-function mutations in the extracellular domain of KIT are common in canine mast cell tumors.
    Letard S; Yang Y; Hanssens K; Palmérini F; Leventhal PS; Guéry S; Moussy A; Kinet JP; Hermine O; Dubreuil P
    Mol Cancer Res; 2008 Jul; 6(7):1137-45. PubMed ID: 18644978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Computational simulations of stem-cell factor/c-kit receptor interaction.
    Menziani MC; Fanelli F; De Benedetti PG
    Proteins; 1996 Sep; 26(1):42-54. PubMed ID: 8880928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of paediatric mastocytosis with a polymorphism resulting in an amino acid substitution (M541L) in the transmembrane domain of c-KIT.
    Foster R; Byrnes E; Meldrum C; Griffith R; Ross G; Upjohn E; Braue A; Scott R; Varigos G; Ferrao P; Ashman LK
    Br J Dermatol; 2008 Nov; 159(5):1160-9. PubMed ID: 18795925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis].
    Sotlar K
    Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in signaling pathways and expression level of the phosphoinositide phosphatase SHIP1 between two oncogenic mutants of the receptor tyrosine kinase KIT.
    Vanderwinden JM; Wang D; Paternotte N; Mignon S; Isozaki K; Erneux C
    Cell Signal; 2006 May; 18(5):661-9. PubMed ID: 15990278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.